Principal Investigators

As of September 1, 2009, the NHLBI has supported hundreds of principal investigators (PIs) with American Recovery and Reinvestment (the Recovery Act) funds, using existing mechanisms, such as expansion of the research paylines from 2008 and 2009, as well as new programs created specifically for the Recovery Act, including Challenge Grants, and Grand Opportunities (GO) grants. Learn more about the scientists who are directing projects or programs supported by grants.

Below are profiles of Recovery Act-funded scientists who provided their photographs to the NHLBI. To find out more about their projects or to see all the NHLBI-funded Recovery Act projects, use the search tool on the right. If you are a PI, please consider sharing your Recovery Act story and photograph for publication on these Web pages.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z     

Naftali Kaminski, M.D. Associate Professor of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania Molecular Phenotypes Within and Across Disease Boundaries in IPF and COPD Administered by the NHLBI Division of Lung Diseases, Airway Biology and Disease Branch FY 2009 Recovery Act Funding: $18,265 More information about the grant

Peter M Kang, M.D. Assistant Professor of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts Apoptosis Inducing Factor in Cardiac Apoptosis Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2009 Recovery Act Funding: $527,240 More information about the grant Additional Funding: Apoptosis Inducing Factor in Cardiac Apoptosis Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2010 Recovery Act Funding: $529,912 More information about the grant Total funding: $1,057,152

George Kelley, D.A., F.A.C.S.M Professor, West Virginia University, Morgantown, West Virginia Aerobic Exercise, Diet and Cholesterol: A Meta-Analysis Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2009 Recovery Act Funding: $139,166 More information about the grant Additional Funding: Aerobic Exercise, Diet and Cholesterol: A Meta-Analysis Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2010 Recovery Act Funding: $120,428 More information about the grant Total funding: $259,594

Steven Kelsen, M.D. Professor of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Temple University School of Medicine, Philadelphia Ancillary Study: Identification of Plasma Biomarkers in COPD Administered by the NHLBI Division of Lung Diseases, Airway Biology and Disease Branch FY 2009 Recovery Act Funding: $784,389 More information about the grant

Raouf A. Khalil, Ph.D. Assistant Professor of Surgery, Brigham and Women's Hospital, Boston, Massachusetts Vascular Mechanisms in Pregnancy-induced Hypertension Administered by the NHLBI Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch FY 2009 Recovery Act Funding: $24,017 More information about the grant

Farrah Kheradmand, M.D. Associate Professor of Medicine and Immunology, Baylor College of Medicine, Houston, Texas Immune Modulators of Inflammation in Severe COPD Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $411,039 More information about the grant Additional Funding: Immune Modulators of Inflammation in Severe COPD Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2010 Recovery Act Funding: $435,346 More information about the grant Total funding: $846,385

Roya Khosravi-Far, Ph.D. Associate Professor of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts Tumor Selective Apoptosis by Trail Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2009 Recovery Act Funding: $266,055 More information about the grant Additional Funding: Tumor Selective Apoptosis by Trail Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2009 Recovery Act Funding: $646,990 More information about the grant Tumor Selective Apoptosis by Trail Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2010 Recovery Act Funding: $632,013 More information about the grant Total funding: $1,545,058

Mark W. Kieran, M.D., Ph.D. Associate Professor of Pediatrics, Harvard Medical School, Boston, Massachusetts Phase II Trial Lonafarnib, Pravastatin, and Zoledronic Acid in Progeria Administered by the NHLBI Division of Cardiovascular Sciences, Heart Development and Structural Diseases Branch FY 2009 Recovery Act Funding: $1,662,201 More information about the grant

Abby King, Ph.D. Professor of Health Research and Policy and of Medicine, Stanford University Medical Center, Stanford, California Modifying Physical Activity and Sedentary Behavior via Mobile Phone Technology Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2009 Recovery Act Funding: $498,741 More information about the grant Additional Funding: Modifying Physical Activity and Sedentary Behavior via Mobile Phone Technology Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2010 Recovery Act Funding: $468,637 More information about the grant Total funding: $967,378

Elizabeth Klerman, M.D., Ph.D. Associate Professor, Harvard Medical School, Boston, Massachusetts Human Circadian Sensitivity to Very Short Light Pulses Administered by the NHLBI Division of Lung Diseases, National Center on Sleep Disorders Branch FY 2009 Recovery Act Funding: $642,690 More information about the grant

Jay K. Kolls, M.D. Professor of Genetics and Pediatrics, Louisiana State University, New Orleans, Louisiana IL-23 / IL-17 and Lung Host Defense Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $7,690 More information about the grant Additional Funding: CD8 T-Cells and Host Defense Against P. CARINII Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $7,690 More information about the grant Total funding: $15,380

David F. Kong, M.D. Assistant Professor of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina ACC/Duke Partnership for a National Cardiovascular Research Infrastructure (NCRI) Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2009 Recovery Act Funding: $1,328,715 More information about the grant

Darrell Kotton, M.D. Assistant Professor, Boston University School of Medicine, Boston, Massachusetts Characterization of Human Hematopoietic and Endodermal Progenitors Derived from iPS Cells Free of Reprogramming Transgenes Administered by the NHBLI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $1,396,542 More information about the grant

William E. Kraus, M.D., F.A.H.A., F.A.C.C., F.A.C.S.M. Professor of Medicine (tenure), Duke University, Durham, North Carolina Genetic Mediators of Metabolic Cardiovascular Disease Risk Administered by the NHLBI Division of Cardiovascular Sciences, Advanced Technologies and Surgery Branch FY 2009 Recovery Act Funding: $1,820,437 More information about the grant

Ronald M. Krauss, M.D. Senior Scientist, Children's Hospital Research Center at Oakland, Oakland, California HMG-CoA Reductase Alternative Splicing and LDL Response to Statin Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2009 Recovery Act Funding: $240,000 More information about the grant Additional Funding: HMG-CoA Reductase Alternative Splicing and LDL Response to Statin Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2010 Recovery Act Funding: $200,000 More information about the grant Total funding: $440,000

Nancy Kressin, Ph.D. Director, Health/Care Disparities Research Program, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts Massachusetts Health Disparities Monitoring System Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2009 Recovery Act Funding: $1,886,428 More information about the grant Additional Funding: Massachusetts Health Disparities Monitoring System Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2010 Recovery Act Funding: $1,673,516 More information about the grant Total funding: $3,559,944

Sunil Kripalani, M.D., M.Sc., F.H.M., Ph.D. Associate Professor, Vanderbilt University, Nashville, Tennessee Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2009 Recovery Act Funding: $168,431 More information about the grant

Irving L. Kron, M.D. Professor of Surgery, University of Virginia, Charlottesville, Virginia Adenosine Receptor Activation in Pulmonary Ischemia-Reperfusion Injury Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $18,550 More information about the grant

Calvin Kuo, M.D. Associate Professor of Hematology, Stanford University Medical Center, Stanford, California VEGF Regulation of Hepatic Erythropoietin Synthesis Administered by the NHLBI Division of Blood Diseases and Resources, Blood Diseases Branch FY 2009 Recovery Act Funding: $187,911 More information about the grant

Periannan Kuppusamy, Ph.D. Professor of Internal Medicine, The Ohio State University, Columbus, Ohio PTENuating Restenosis: An Innovative PTEN Promoter for Cardioprotection Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2009 Recovery Act Funding: $187,500 More information about the grant Additional Funding: PTENuating Restenosis: An Innovative PTEN Promoter for Cardioprotection Administered by the NHLBI Division of Cardiovascular Sciences, Atherothrombosis and Coronary Artery Disease Branch FY 2010 Recovery Act Funding: $225,000 More information about the grant Total funding: $412,500

Michael Kyba, Ph.D. Assistant Professor, Department of Pediatrics; Lillehei Endowed Scholar, Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota Probing the Hematopoietic Hox Code Administered by the NHLBI Division of Blood Diseases and Resources, Transfusion Medicine and Cellular Therapeutics Branch FY 2009 Recovery Act Funding: $18,724 More information about the grant Additional Funding: Probing the Hematopoietic Hox Code Administered by the NHLBI Division of Blood Diseases and Resources, Transfusion Medicine and Cellular Therapeutics Branch FY 2009 Recovery Act Funding: $256,096 More information about the grant Lineage-Specific Reprogramming to Blood with a Transcription Factor Cocktail Administered by the NHLBI Division of Blood Diseases and Resources, Transfusion Medicine and Cellular Therapeutics Branch FY 2009 Recovery Act Funding: $354,349 More information about the grant Total funding: $629,169

Last Updated: March 16, 2010